Commonwealth of Pennsylvania Public School Empls Retrmt SYS Grows Stock Holdings in Albemarle Co. (NYSE:ALB)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Albemarle Co. (NYSE:ALBFree Report) by 15.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,595 shares of the specialty chemicals company’s stock after buying an additional 3,131 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Albemarle were worth $4,012,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ALB. Assetmark Inc. acquired a new stake in shares of Albemarle in the third quarter worth $25,000. Covestor Ltd grew its holdings in Albemarle by 51.2% during the 1st quarter. Covestor Ltd now owns 130 shares of the specialty chemicals company’s stock valued at $29,000 after purchasing an additional 44 shares in the last quarter. PrairieView Partners LLC grew its holdings in Albemarle by 15,300.0% during the 2nd quarter. PrairieView Partners LLC now owns 154 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 153 shares in the last quarter. City State Bank grew its holdings in Albemarle by 60.0% during the 3rd quarter. City State Bank now owns 200 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 75 shares in the last quarter. Finally, AllSquare Wealth Management LLC grew its holdings in Albemarle by 87.0% during the 2nd quarter. AllSquare Wealth Management LLC now owns 172 shares of the specialty chemicals company’s stock valued at $35,000 after purchasing an additional 80 shares in the last quarter. 84.71% of the stock is currently owned by institutional investors and hedge funds.

Albemarle Price Performance

NYSE ALB opened at $115.78 on Monday. The company has a quick ratio of 0.94, a current ratio of 1.81 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $13.59 billion, a PE ratio of 4.11, a price-to-earnings-growth ratio of 1.55 and a beta of 1.61. The company has a 50 day moving average price of $129.95 and a two-hundred day moving average price of $151.43. Albemarle Co. has a 12-month low of $108.39 and a 12-month high of $293.01.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ALB. Piper Sandler lowered shares of Albemarle from a “neutral” rating to an “underweight” rating and decreased their price objective for the stock from $140.00 to $128.00 in a report on Tuesday, December 5th. TheStreet downgraded shares of Albemarle from a “b-” rating to a “c+” rating in a research report on Monday, November 6th. Deutsche Bank Aktiengesellschaft downgraded shares of Albemarle from a “buy” rating to a “hold” rating and reduced their price target for the stock from $155.00 to $135.00 in a research report on Thursday, January 11th. StockNews.com downgraded shares of Albemarle from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Finally, Oppenheimer cut their price objective on shares of Albemarle from $308.00 to $191.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 17th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, Albemarle presently has an average rating of “Hold” and a consensus target price of $200.16.

Read Our Latest Stock Report on Albemarle

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.

Read More

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.